Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
This study assessed the efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, for the treatment of Japanese patients with palmoplantar pustulosis refractory to topical therapy.
Dermatologists are often the first to see suspected mpox cases. Review its differential diagnosis, mode of transmission, prevention, and available treatments in this paper.
Review current understanding of the major mechanisms involved in the pathogenesis of vitiligo and its most common available treatments, with a focus on the newly approved JAK1 and JAK2 inhibitors.
This paper summarizes current understanding of the etiology of cholinergic urticaria and its various subtypes. How should therapeutic management be approached for each specific subtype?
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial.
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2.
Mission Statement:
The American Journal of Clinical Dermatology promotes rational therapy and effective patient management within the discipline of dermatology by providing a regular program of independent review articles covering all aspects of the management of dermatological conditions, particularly the place in therapy of newer and established agents and procedures.
